Friday - April 26, 2024

Industry Update: Innocan Pharma Accelerates Commercialization in Europe Following Impressive Revenue Growth

Innocan Pharma is well-positioned to become a leading player in therapeutics and consumer wellness products, having achieved impressive revenue growth through its subsidiary, and expanding distribution network. With the launch of its licensing and commercialization strategy work in the veterinary … Continue reading